Related Experiment Videos
Short-term plasmapheresis in acute lupus nephritis
The International Journal of Artificial Organs
|July 1, 1983
Summary
Short-term plasmapheresis combined with immunosuppressive therapy rapidly improved acute lupus nephritis symptoms in 11 patients. This treatment reduced immune complexes, anti-DNA antibodies, and improved kidney function and lymphocyte activity.
Area of Science:
- Nephrology
- Immunology
- Rheumatology
Background:
- Acute lupus nephritis is a severe complication of systemic lupus erythematosus.
- Prompt and effective treatment is crucial to prevent irreversible kidney damage.
Purpose of the Study:
- To evaluate the efficacy of short-term plasmapheresis combined with immunosuppressive therapy in patients with acute lupus nephritis.
Main Methods:
- 11 patients with acute lupus nephritis received short-term plasmapheresis (mean 6.2 sessions) and immunosuppressive therapy.
- Plasma exchange involved removing 80% of total plasma volume per session using centrifuge or membrane filters.
Main Results:
- All patients showed rapid improvement in clinical symptoms.
- Five patients with initial renal insufficiency experienced reduced serum creatinine and proteinuria.
- Immunological markers, including circulating immune complexes and anti-DNA antibodies, decreased rapidly.
- Lymphocyte function, assessed by E rosettes and Con A induced suppressor activity, improved.
Conclusions:
- Short-term plasmapheresis combined with immunosuppressive therapy is an effective treatment for acute lupus nephritis.
- This therapeutic approach can rapidly ameliorate clinical manifestations and improve renal function.
- The treatment positively impacts key immunological parameters associated with lupus nephritis activity.